Related Experiment Video

Updated: Sep 7, 2025

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.2K

The current treatment approach to adolescents and young adults with acute lymphoblastic leukemia (AYA-ALL):

Hasmukh Jain1, Akhil Rajendra1, Manju Sengar1

  • 1Department of Medical Oncology, Tata Memorial Hospital, Parel, Mumbai, India.

Expert Review of Anticancer Therapy
|June 23, 2022
PubMed

Insights

Adolescent and Young Adult Acute Lymphoblastic Leukemia (AYA-ALL) requires specialized care due to unique challenges. Pediatric-inspired treatments show promise, but more research and clinical trials are essential for improved outcomes.

Area of Science:

  • Hematology
  • Oncology
  • Clinical Research

Background:

  • Adolescent and Young Adult Acute Lymphoblastic Leukemia (AYA-ALL) presents distinct clinical, biological, and psychosocial challenges compared to pediatric ALL.
  • Outcomes for AYA-ALL are generally inferior to those in pediatric patients, highlighting a critical unmet need in this age group.

Purpose of the Study:

  • To review the unique characteristics of AYA-ALL in comparison to pediatric and older adult ALL.
  • To summarize current research, risk-stratified approaches, and novel therapeutic strategies for AYA-ALL.

Main Methods:

  • This review synthesizes existing literature on AYA-ALL, including clinical studies, biological subtypes, and treatment outcomes.
  • Comparative analyses between AYA-ALL, pediatric ALL, and older adult ALL are discussed.

Main Results:

  • Pediatric-inspired treatment protocols are increasingly recognized as superior for AYA-ALL compared to traditional adult protocols.
  • Despite progress, significant questions remain unanswered due to a lack of large-scale, randomized clinical trials specifically for the AYA cohort.

Conclusions:

  • AYA-ALL is a complex disease necessitating multidisciplinary and targeted care approaches.
  • Further well-designed clinical trials focused on the AYA population are crucial to enhance treatment efficacy and patient outcomes.
Abstract

Keywords:
Adolescent and young adultPh-like ALLPh-positive ALLacute lymphoblastic leukemiaearly T precursor-ALLminimal residual diseaserisk-stratification

More Related Videos

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation09:09

Preparation of Primary Acute Lymphoblastic Leukemia Cells in Different Cell Cycle Phases by Centrifugal Elutriation

Published on: November 10, 2017

8.4K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.4K

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
489
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
652